Adding Multimedia FDA Approves Herceptin For HER2-Positive Metastatic Stomach...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced the U.S. Food and Drug Administration (FDA) has approved Herceptin® (trastuzumab) in combination with chemotherapy...
View ArticleCombining Genomics And Current Medicines Holds Great Promise For Personalized...
Using recent advances in genomics, researchers have uncovered a genetic pathway that affects the development of breast cancer, work that could help predict which patients are at risk of relapse for the...
View ArticleCombination Overcomes Breast Cancer Resistance To Herceptin
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor’s vulnerability to treatment, scientists at The...
View ArticleScientists Target Aggressive Prostate Cancer
Researchers at the University of Michigan Comprehensive Cancer Center have identified a potential target to treat an aggressive type of prostate cancer. The target, a gene called SPINK1, could be to...
View ArticleBenefits Of Two Breast Cancer Drugs Still Unproven, Says Latest Draft Guidance
he clinical and cost effectiveness of two breast cancer drugs that may be offered alongside hormone therapy to some postmenopausal women who have a particular type of the disease has not been clearly...
View Article
